Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mosquito larval midgut protein receptors are a specialized group of proteins located on the brush border membrane of the larval digestive tract, serving as the primary targets for biological larvicides. These receptors include cadherin-like proteins, aminopeptidase N (APN), alkaline phosphatase (ALP), and ATP-binding cassette (ABC) transporters, which are essential for the insect's digestive and physiological processes [1, 3, 6]. They are specifically targeted by insecticidal toxins produced by bacteria such as Bacillus thuringiensis israelensis (Bti) and Lysinibacillus sphaericus [2, 5]. Upon ingestion, these toxins are activated in the highly alkaline environment of the larval midgut and bind to these receptors with high affinity [3, 13]. This binding triggers a cascade of events, including toxin oligomerization and the formation of cation-selective pores in the midgut epithelial cell membrane [6, 10]. The resulting osmotic imbalance leads to cell swelling, lysis, and the eventual death of the larva [13, 15]. Because these receptors and the required alkaline activation conditions are absent in mammals and most non-target organisms, they represent a highly specific and environmentally safe mechanism for vector control [15, 18]. Understanding these receptors is crucial for managing insecticide resistance and developing next-generation biopesticides to combat mosquito-borne diseases like malaria, dengue, and Zika [7, 12].
Toxins are activated in the alkaline larval midgut and bind to specific receptors (cadherin, APN, ALP, ABC transporters), leading to oligomerization, pore formation, osmotic lysis of epithelial cells, and larval death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mosquito larval midgut protein receptors.